Home  /  Resources  /  Whitepapers

Whitepapers.

Expert opinion and insight into industry topics.

Speak to our experts

Tackling Poor Bioavailability with Early Formulation Strategies

Despite its advantages, oral bioavailability remains a critical barrier in early-stage development. Many promising drug candidates fail to reach clinical proof of concept because of insufficient absorption.
Download Whitepaper
WHITEPAPER

Soft Mist Inhalers: Lung deposition benefits for respiratory conditions

Soft mist inhalers produce a slow-moving aerosol with a longer spray duration, which enhances lung deposition and reduces oropharyngeal deposition. Explore their use and application in our whitapaer.
Download Whitepaper
WHITEPAPER

Development of Pulmonary Dosage Forms for the Successful Delivery of Complex Molecules

Explore the growing interest in delivering drugs deep into the alveolar space.
Download Whitepaper
WHITEPAPER

Characterisation of Spray Dried Biologics

Explore how spray drying enables dry powder formulations for nasal, pulmonary, and even injectable delivery routes. Dr. Richard Johnson authors this whitepaper on the advanced characterisation techniques required to support biological molecules through development.
Download Whitepaper
WHITEPAPER

Pharmaceutical Spray Drying: Technology & Applications

Dr. Richard Johnson authors this whitepaper discussing technology and applications of spray drying and why it is one of the most versatile drying processes in the industry.
Download Whitepaper
WHITEPAPER

Transitioning Your Product from Phase 1 to Phase 2 Clinical Studies

This guide explores how a partnership with a CDMO can help to define and implement the best pathways and key considerations when transitioning from a Phase 1 to Phase 2 clinical study.
Download Whitepaper
WHITEPAPER

In Vivo Testing of Nasal Dosage Forms

Dr. Richard Johnson authors this whitepaper discussing growing interest in nasal dosage forms, and the challenges of ensuring proper dosing, efficacy, and safety through in vivo testing.
Download Whitepaper
WHITEPAPER

Spray Drying Biologics: An Alternative to Freeze Drying

Dr. Richard Johnson authors this whitepaper discussing the growth and complexity of dosage forms containing biologics and the alternative drying technologies to traditional freeze drying technology.
Download Whitepaper
WHITEPAPER

Nasal Delivery of Spray Dried Biologics: Opportunities and Challenges

This whitepaper discusses the ability spray dried nasal formulations have to offer offer excellent stability, targeted nasal deposition and enhanced permeation.
Download Whitepaper
WHITEPAPER

Nose to Brain (N2B) Drug Delivery: Benefits and Challenges

This whitepaper explores the growing interest in drug delivery routes through absorption into the bloodstream via the blood-brain barrier.
Download Whitepaper
WHITEPAPER

We're here to help.

Interested in learning more about our CDMO capabilities and expertise?
Speak to our team to discuss your requirements.

Pulmonary Dosage Forms

Explore our expertise in particle engineering and device selection
Explore

Oral Dosage Forms

Whatever the oral product, Upperton's expertise will help you develop it
Discover

Nasal Dosage Forms

Learn more about successful nasal delivery of small molecules and biologics
Learn more

Download Our Fact Sheet: The New Rules of CDMO Partnerships

What Biotechs Should Be Looking For Next

Let's Talk.

Book a discovery call.

Speak with our team of experts and set up a discovery call to discuss your project in more detail.